4Modlin IM, Kidd M, Pfragner R, et al. The functional character- ization of normal and neoplastic human enterochromaffin cells [J]. J C/in Endocrinol Metab,2006, 91 (6) :2340-2348.
5Yao JC, Hassan M, Phan A, et al. One hundred years after "caz'cinoid" : epidemiology of and prognostic factors for neuroen- docrine tumors in 35,825 cases in the United States[ J]. J Clin Oneo1.2008.26 ( 18 ) :3063 - 3072.
6Modlin IM, Lye KD, Kidd M. A 5-decade analysis of 13,715 carcinoid tumors [ J ]. Cancer,2003,97 (4) :934 - 959.
7ho T, Sasano H, Tanaka M, et al. Epidemiological study of gas- troenteropancreatic neuroendocrine tumors in Japan [ J ]. J Gas- troentero1,2010,45 ( 2 ) : 234 - 243.
8Wang YH, Lin Y, Xae L, et al. Relationship between clinical characteristics and survival of gastroenteropancreatic neuroendo- crine neoplasms: A single-institution analysis (1995-2012) in South China[ J] BMC Endocr Disord,2012 ,12 :30.
9Oberg KE. Gastrointestinal neuroendocrine tumors[ J]. Ann On- col ,2010,21 ( Suppl 7 ) : vii 72 - vii 80.
10Jensen RT, Niederle B, Mitry E, et al. Gastrinoma (duodenal and pancreatic ) [ J ]. Neuroendocrinology, 2006,84 ( 3 ) : 173 - 182.
